Surgical resection has been considered the only curative option for patients with pancreatic cancer. Nonoperative local treatment options that can provide a similar benefit are needed. Emerging radiation techniques that address organ motion have enabled curative radiation doses to be given to patients with inoperable disease.
A recent study on patients with inoperable LAPC found that A-RT following multiagent induction therapy for locally advanced pancreatic cancer was associated with durable locoregional tumor control and favorable survival. Read more . . .